{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=277724", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=277724", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=277724&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=277724", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=277724", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=277724", "items" : [{"_about" : "http://data.parliament.uk/resources/1139369", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139369/answer", "answerText" : {"_value" : "
NHS England does not believe that the closure of the Commissioning Support Programme will leave a gap in the review of treatments.<\/p>
The topics that would have been referred to the Commissioning Support Programme will now be routed to the appropriate appraisal programme, undertaken by the National Institute for Health and Care Excellence (NICE), except where there is a clear rationale not to do so. NICE expects to implement this expansion from April 2020. It will be in a position to start progressing topics through the NICE topic selection process from the summer of 2019.<\/p>
All policy propositions relating to topics previously being supported in development through the Commissioning Support Programme have been handed over at the agreed stage as for all topics, post stakeholder testing. These are now being progressed though the usual development process. This process is set out in \u2018Methods: National Clinical Policies\u2019 at the following link:<\/p>